Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T17:08:42.548Z.
Calculation as of: 2026-10-06T17:08:42.548Z.
Quote observation: 2026-10-06T17:05:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ee39d499936ebaa3412950651821bd8c7319a7e70273e63a1b15e5f1ca5028da
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$416.52M
EV/FCF Ratio
N/A
TTM Avg
3927.74x
3Y Avg
907.14x
5Y Avg
462.84x
Market Cap
$422.04M
EV/FCF Ratio
N/A
TTM Avg
98.46x
3Y Avg
98.46x
5Y Avg
98.46x
Market Cap
$413.10M
EV/FCF Ratio
N/A
TTM Avg
32.08x
3Y Avg
32.08x
5Y Avg
32.08x
Market Cap
$410.81M
EV/FCF Ratio
N/A
TTM Avg
196.27x
3Y Avg
196.27x
5Y Avg
196.27x
Market Cap
$407.99M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Senseonics Holdings, Inc. (SENS) | $418.36M | N/A | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $416.52M | N/A | 3927.74x | 907.14x | 462.84x |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $422.04M | N/A | 98.46x | 98.46x | 98.46x |
| Prothena Corporation plc (PRTA)vs › | $413.10M | N/A | 32.08x | 32.08x | 32.08x |
| Rezolute, Inc. (RZLT)vs › | $412.95M | N/A | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $410.81M | N/A | 196.27x | 196.27x | 196.27x |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $407.99M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $409.37M | N/A | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $409.04M | N/A | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $408.54M | N/A | 5.74x | 5.74x | 5.74x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
